TY - JOUR
T1 - Economic burden for informal caregivers of lung and colorectal cancer patients
AU - van Houtven, Courtney Harold
AU - Ramsey, Scott D.
AU - Hornbrook, Mark C.
AU - Atienza, Audie A.
AU - van Ryn, Michelle
PY - 2010
Y1 - 2010
N2 - Background. Informal care provides many benefits to cancer patients, but can be costly to caregivers. This study quantified the economic burden for informal caregivers of lung cancer (LC) and colorectal cancer (CRC) patients, examining differences by cancer type, phase of disease, stage at diagnosis, patient age, and relationship. Methods. A cross-sectional survey of caregivers of LC and CRC patients participating in the Share Thoughts on Care survey was conducted. Economic burden was calculated using the opportunity cost of caregiver time, the value of work hours lost, and out-of-pocket expenditures. Factors associated with economic burden to caregivers were modeled using fixed-effects generalized least squares estimation. Results. Informal caregivers (1,629) completed mailed surveys. Of these, 663, 822, and 144 were surveyed during the patient's initial phase (first year after diagnosis, not within 6 months of death), continuing phase (after 1 year, not within 6 months of death), and terminal phase (within 6 months of death) of disease, respectively. The accumulated economic burdens for caregivers were $7,028, $19,701, and $14,234 for those evaluated during the patient's initial phase, continuing phase, and terminal phase of disease, respectively. Economic burden was higher for caregivers of LC patients than CRC patients (p =.044) and for caregivers of patients diagnosed at stage 4 versus stage 1 (p =.001). Spouses faced higher economic burden than other relatives (p =.000) or friends (p =.000). Conclusions. Economic burden for informal caregivers of LC and CRC patients is substantial and should be included in estimates of the societal cost of cancer care.
AB - Background. Informal care provides many benefits to cancer patients, but can be costly to caregivers. This study quantified the economic burden for informal caregivers of lung cancer (LC) and colorectal cancer (CRC) patients, examining differences by cancer type, phase of disease, stage at diagnosis, patient age, and relationship. Methods. A cross-sectional survey of caregivers of LC and CRC patients participating in the Share Thoughts on Care survey was conducted. Economic burden was calculated using the opportunity cost of caregiver time, the value of work hours lost, and out-of-pocket expenditures. Factors associated with economic burden to caregivers were modeled using fixed-effects generalized least squares estimation. Results. Informal caregivers (1,629) completed mailed surveys. Of these, 663, 822, and 144 were surveyed during the patient's initial phase (first year after diagnosis, not within 6 months of death), continuing phase (after 1 year, not within 6 months of death), and terminal phase (within 6 months of death) of disease, respectively. The accumulated economic burdens for caregivers were $7,028, $19,701, and $14,234 for those evaluated during the patient's initial phase, continuing phase, and terminal phase of disease, respectively. Economic burden was higher for caregivers of LC patients than CRC patients (p =.044) and for caregivers of patients diagnosed at stage 4 versus stage 1 (p =.001). Spouses faced higher economic burden than other relatives (p =.000) or friends (p =.000). Conclusions. Economic burden for informal caregivers of LC and CRC patients is substantial and should be included in estimates of the societal cost of cancer care.
KW - Cancer caregiving
KW - Colorectal cancer
KW - Informal care
KW - Lung cancer
KW - Opportunity costs
KW - Out-of-pocket costs
KW - Phase of disease
KW - Stage of disease
UR - http://www.scopus.com/inward/record.url?scp=77956797783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956797783&partnerID=8YFLogxK
U2 - 10.1634/theoncologist.2010-0005
DO - 10.1634/theoncologist.2010-0005
M3 - Article
C2 - 20667966
AN - SCOPUS:77956797783
SN - 1083-7159
VL - 15
SP - 883
EP - 893
JO - Oncologist
JF - Oncologist
IS - 8
ER -